{"cited_by_count":2663423,"description":"This cluster of papers focuses on the systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), covering topics such as classification criteria, autoantibody development, interferon-inducible genes, nephritis, B lymphocyte depletion therapy, thrombosis risk, immunopathogenesis, toll-like receptors, and the epidemiology of autoimmune diseases. The research aims to improve understanding, diagnosis, classification, and management of SLE and APS.","display_name":"Systemic Lupus Erythematosus Research","domain_id":"4","external_ids":{"openalex":"https://openalex.org/T10308","wikipedia":"https://en.wikipedia.org/wiki/Systemic_lupus_erythematosus"},"field_id":"27","id":"T10308","keywords":[{"display_name":"systemic lupus erythematosus","id":"systemic-lupus-erythematosus","score":0.6633,"url":"https://openalex.org/keywords/systemic-lupus-erythematosus"},{"display_name":"lupus nephritis","id":"lupus-nephritis","score":0.7629,"url":"https://openalex.org/keywords/lupus-nephritis"},{"display_name":"antiphospholipid syndrome","id":"antiphospholipid-syndrome","score":0.7324,"url":"https://openalex.org/keywords/antiphospholipid-syndrome"},{"display_name":"antiphospholipid antibodies","id":"antiphospholipid-antibodies","score":0.7422,"url":"https://openalex.org/keywords/antiphospholipid-antibodies"},{"display_name":"antinuclear antibodies","id":"antinuclear-antibodies","score":0.4143,"url":"https://openalex.org/keywords/antinuclear-antibodies"},{"display_name":"anti-dsDNA antibodies","id":"anti-dsdna-antibodies","score":0.8502,"url":"https://openalex.org/keywords/anti-dsdna-antibodies"},{"display_name":"anticardiolipin antibodies","id":"anticardiolipin-antibodies","score":0.732,"url":"https://openalex.org/keywords/anticardiolipin-antibodies"},{"display_name":"lupus anticoagulant","id":"lupus-anticoagulant","score":0.7456,"url":"https://openalex.org/keywords/lupus-anticoagulant"},{"display_name":"cutaneous lupus erythematosus","id":"cutaneous-lupus-erythematosus","score":0.7427,"url":"https://openalex.org/keywords/cutaneous-lupus-erythematosus"},{"display_name":"pediatric lupus","id":"pediatric-systemic-lupus-erythematosus","score":0.8126,"url":"https://openalex.org/keywords/pediatric-systemic-lupus-erythematosus"},{"display_name":"neuropsychiatric lupus","id":"neuropsychiatric-systemic-lupus-erythematosus","score":0.8832,"url":"https://openalex.org/keywords/neuropsychiatric-systemic-lupus-erythematosus"},{"display_name":"anti-DNA antibodies","id":"anti-dna-antibodies","score":0.7855,"url":"https://openalex.org/keywords/anti-dna-antibodies"},{"display_name":"lupus erythematosus","id":"lupus-erythematosus","score":0.5709,"url":"https://openalex.org/keywords/lupus-erythematosus"},{"display_name":"SLEDAI","id":"sledai","score":0.9207,"url":"https://openalex.org/keywords/sledai"},{"display_name":"anti-beta2-glycoprotein I antibodies","id":"anti-beta2-glycoprotein-i-antibodies","score":0.8592,"url":"https://openalex.org/keywords/anti-beta2-glycoprotein-i-antibodies"},{"display_name":"anti-SSA antibodies","id":"anti-ssa-antibodies","score":0.4676,"url":"https://openalex.org/keywords/anti-ssa-antibodies"},{"display_name":"discoid lupus erythematosus","id":"discoid-lupus-erythematosus","score":0.6127,"url":"https://openalex.org/keywords/discoid-lupus-erythematosus"},{"display_name":"MRL/lpr mice","id":"mrl-lpr-mice","score":0.7143,"url":"https://openalex.org/keywords/mrl-lpr-mice"},{"display_name":"lupus","id":"lupus","score":0.4177,"url":"https://openalex.org/keywords/lupus"},{"display_name":"beta2-glycoprotein I","id":"beta2-glycoprotein-i","score":0.6364,"url":"https://openalex.org/keywords/beta2-glycoprotein-i"},{"display_name":"lupus flares","id":"lupus-flares","score":0.8425,"url":"https://openalex.org/keywords/lupus-flares"},{"display_name":"belimumab","id":"belimumab","score":0.7473,"url":"https://openalex.org/keywords/belimumab"},{"display_name":"drug-induced lupus","id":"drug-induced-lupus-erythematosus","score":0.728,"url":"https://openalex.org/keywords/drug-induced-lupus-erythematosus"},{"display_name":"anti-Sm antibodies","id":"anti-sm-antibodies","score":0.8562,"url":"https://openalex.org/keywords/anti-sm-antibodies"},{"display_name":"NZB/W F1 mice","id":"nzb-w-f1-mice","score":0.7966,"url":"https://openalex.org/keywords/nzb-w-f1-mice"}],"legacy_keywords":["Systemic Lupus Erythematosus","Antiphospholipid Syndrome","Autoantibodies","Interferon-inducible Genes","Lupus Nephritis","B Lymphocyte Depletion","Thrombosis Risk","Immunopathogenesis","Toll-like Receptors","Autoimmune Disease Epidemiology"],"openalex_id":"https://openalex.org/T10308","source_created_date":"2024-01-23T15:27:06","source_updated_date":"2026-10-17T03:02:00","subfield_id":"2745","url":"/topics/T10308","works_api_url":"https://api.openalex.org/works?filter=topics.id:T10308","works_count":171315,"label":"Systemic Lupus Erythematosus Research","provider":"openalex","revision":"8c4d08a4a8b58ae2","taxonomy_revision":"f050b5d4780b1289","title":"Systemic Lupus Erythematosus Research","kind":"topic-directory","aeo_cohort":"topic-directory","catalogue_revision":"f050b5d4780b1289","numeric_address":"36240179341977894","address_version":"morton4x16-v1","coordinates":[4,27,2745,10308],"answer_status":"Directory metadata; local answer requires separate source review","truth_status":"Subject descriptor, not a factual answer or a demonstrated knowledge gap","reviewed_answer":null}